Sabril and Robinul drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Sabril (vigabatrin) and Robinul (glycopyrrolate). Common drug interactions include hypersomnia among females and atelectasis among males.
The phase IV clinical study analyzes what interactions people have when they take Sabril and Robinul. It is created by eHealthMe based on reports of 43 people who take the same drugs from the FDA, and is updated regularly.
What is Sabril?
Sabril has active ingredients of vigabatrin. eHealthMe is studying from 12,445 Sabril users. Check the latest studies of Sabril.
What is Robinul?
Robinul has active ingredients of glycopyrrolate. It is often used in hyperhidrosis. eHealthMe is studying from 1,663 Robinul users. Check the latest studies of Robinul.
43 people who take Sabril and Robinul together, and have interactions are studied.

What are the common drug interactions of Sabril and Robinul, by gender? *:
female:
- Hypersomnia (excessive daytime sleepiness (eds))
- Seizure (abnormal excessive or synchronous neuronal activity in the brain)
- Death
- Optic atrophy (the loss of a proportion of optic disc nerve fibres)
- Pneumonia
- Abdominal discomfort
- Diarrhoea
- Nausea (feeling of having an urge to vomit)
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Neurogenic bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion)
male:
- Atelectasis (partial or complete collapse of the lung)
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Hypoglycaemia (deficiency of glucose in the bloodstream)
- Neonatal disorder (disease of neonates)
- Pyrexia (fever)
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Viral infection
- Infantile spasms
- Abnormal behaviour
- Adverse event
What are the common drug interactions of Sabril and Robinul, by age (0-1 to 60+)? *:
0-1:
- Neonatal disorder (disease of neonates)
- Upper respiratory tract infection
- Viral infection
- Death
- Nasopharyngitis (inflammation of the nasopharynx)
- Pneumonia viral
- Seizure (abnormal excessive or synchronous neuronal activity in the brain)
- Dysphagia (a condition in which swallowing is difficult or painful)
- Hospitalisation
- Lung infection
2-9:
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Respiratory distress (difficulty in breathing)
- Seizure (abnormal excessive or synchronous neuronal activity in the brain)
- Hypoglycaemia (deficiency of glucose in the bloodstream)
- Pneumonia
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)
- Adverse event
- Bacterial tracheitis (bacterial infection of the trachea)
- Bradycardia (abnormally slow heart action)
10-19:
- Hypersomnia (excessive daytime sleepiness (eds))
- Seizure (abnormal excessive or synchronous neuronal activity in the brain)
- Abdominal discomfort
- Diarrhoea
- Nausea (feeling of having an urge to vomit)
- Abnormal behaviour
- Aggression
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Adverse drug reaction
- Cardiac arrest
20-29:
- Apnoea (suspension of external breathing)
- Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
- Seizure cluster (small group of seizure)
- Urinary tract infection
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
n/a
What are the existing conditions these people have? *
- Infantile Spasms: 20 people, 46.51%
- Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 14 people, 32.56%
- Seizures (abnormal excessive or synchronous neuronal activity in the brain): 11 people, 25.58%
- Wheezing (a high-pitched whistling sound made while you breath): 6 people, 13.95%
- Pain: 5 people, 11.63%
- Dyspnea (difficult or laboured breathing): 5 people, 11.63%
- Constipation: 5 people, 11.63%
- Hypersensitivity: 4 people, 9.30%
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 4 people, 9.30%
- Seizure Cluster (small group of seizure): 3 people, 6.98%
* Approximation only. Some reports may have incomplete information.
Do you take Sabril and Robinul?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Sabril and Robinul:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Sabril:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Robinul:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Sabril and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Robinul and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- D'souza S, Gowler V, "Glycopyrrolate‐induced respiratory arrest: an unusual side effect", Acta Anaesthesiologica Scandinavica, 2015 Mar .
- D'souza S, Gowler V, "Glycopyrrolate‐induced respiratory arrest: an unusual side effect", Acta Anaesthesiologica Scandinavica, 2015 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on vigabatrin and glycopyrrolate (the active ingredients of Sabril and Robinul, respectively), and Sabril and Robinul (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Senna cause Cauda Equina Syndrome? - 7 seconds ago
- Drug interactions of Enalapril Maleate and Alphagan P - 19 seconds ago
- Urinary Incontinence Aggravated and drugs of ingredients of diltiazem hydrochloride - 32 seconds ago
- Nph Insulin and Crohn'S Disease for Women aged 50-59 - 33 seconds ago
- Nph Insulin and Crohns for Women aged 50-59 - 34 seconds ago
- Nph Insulin and Crohns Disease for Women aged 50-59 - 34 seconds ago
- Nph Insulin and Regional Enteritis for Women aged 50-59 - 34 seconds ago
- Nph Insulin and Inflammatory Bowel Disease - Crohn'S Disease for Women aged 50-59 - 34 seconds ago
- Nph Insulin and Granulomatous Ileocolitis for Women aged 50-59 - 35 seconds ago
- Nph Insulin and Ileitis for Women aged 50-59 - 35 seconds ago